The continued progress in malaria control may tempt countries to stagnate their financial commitment to control and elimination efforts. However, this article outlines the benefits—both for health and wealth—of continued support for malaria interventions.
Describes progress over the last 15 years and anticipated challenges. Importantly, the article emphasizes the importance of intra-regional collaboration, mentioning the Global Fund EMMIE program in Central America and the E8 initiative in southern Africa, among others.
Studies have shown that supply chain costs are a significant proportion of total programme costs. The purpose of this research was to estimate the country level costs of the public sector supply chain for artemisinin-based combination therapy (ACT) and rapid diagnostic tests (RDTs) from the central to the peripheral levels in Benin and Kenya.